These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20448132)

  • 1. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction.
    Ozhan H; Balaban Y
    Heart; 2010 May; 96(10):791; author reply 791. PubMed ID: 20448132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
    N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's old is new again. Spironolactone and heart failure.
    Lock M; Chun R
    Can Fam Physician; 1999 Nov; 45():2621-2. PubMed ID: 10587769
    [No Abstract]   [Full Text] [Related]  

  • 5. My approach to patients with heart failure and a normal ejection fraction.
    Pitt B
    Trends Cardiovasc Med; 2015 Feb; 25(2):164-5. PubMed ID: 25592236
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of spironolactone in a specialized heart failure clinic.
    Sligl W; McAlister FA; Ezekowitz J; Armstrong PW
    Am J Cardiol; 2004 Aug; 94(4):443-7. PubMed ID: 15325926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C; Wani M; Steward J; O'Mahony MS
    Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview of current chronic heart failure therapy.
    Moore CK
    J Miss State Med Assoc; 2000 Apr; 41(4):549-51. PubMed ID: 10790951
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure.
    Cicoira M; Rossi A; Bonapace S; Zanolla L; Perrot A; Francis DP; Golia G; Franceschini L; Osterziel KJ; Zardini P
    Am J Med; 2004 May; 116(10):657-61. PubMed ID: 15121491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of spironolactone use on heart failure mortality: a population-based study.
    Ouzounian M; Hassan A; Cox JL; Johnstone DE; Howlett J;
    J Card Fail; 2007 Apr; 13(3):165-9. PubMed ID: 17448412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical test of a diuretic preparation combining a spironoloctone and a sulfonamide derivative].
    Casanova P; Delboy C
    Mars Med; 1965; 102(6):551-8. PubMed ID: 5320169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
    Feola M; Menardi E; Ribichini F; Vado A; Deorsola A; Ferrero V; Visconti G; Milanese U; Uslenghi E
    Med Sci Monit; 2003 Aug; 9(8):CR341-5. PubMed ID: 12942029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone use in patients with heart failure.
    Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
    J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone in left-sided heart failure: how does it fit in?
    Margo KL; Luttermoser G; Shaughnessy AF
    Am Fam Physician; 2001 Oct; 64(8):1393-8. PubMed ID: 11681781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic heart insufficiency should be treated also with spironolactone].
    Kjeldsen KP; Nørgaard A; Thygesen K
    Ugeskr Laeger; 1999 Sep; 161(37):5132. PubMed ID: 10523942
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical study of verospirone and spironolactone.
    Gãbor G; Bekes M; Polãk G; Rausch J; Gulyãs A
    Ther Hung; 1972; 20(1):36-45. PubMed ID: 5076528
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G; Klüsener W
    Med Klin; 1981 Jan; 76(1):20-3. PubMed ID: 7254119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.